v3.26.1
ACQUISITION (Details Narrative)
Oct. 11, 2024
USD ($)
Renu Laboratories, Inc [Member]  
Business Combination [Line Items]  
Purchase price $ 1,780,000
Goldman's Pharmaceuticals LLC [Member]  
Business Combination [Line Items]  
Ownership interest, percentage 100.00%
ELRT Technologies, LLC [Member]  
Business Combination [Line Items]  
Ownership interest, percentage 50.00%